M&A
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
Pluristyx
PR-M10-22-04Oct 06, 2022
Stem Cells
Pluristyx and Accelerated Biosciences Announce Availability of Clinical-Grade Immune-Privileged Human Trophoblast Stem Cells (hTSCs)
Pluristyx
PR-M04-22-15Apr 28, 2022
Stem Cells
Delivering Pluripotent Stems Cells Primed to Differentiate
Pluristyx
PAO-04-22-R250-71Apr 26, 2022